Not every test that can be done should be done
As the body ages past sixty-five, the medical protocols designed to protect it do not always age with the same wisdom. A growing consensus among clinicians suggests that routine screenings and treatments, long applied by reflex, may offer diminishing returns for older adults — and in some cases, cause more harm than the conditions they seek to prevent. The deeper question medicine is now asking is not merely what can be done, but what ought to be done, and for whom.
- Screening tests built for younger bodies are still being routinely ordered for patients in their seventies and eighties, even when the evidence for benefit has quietly eroded.
- Overtreatment in elderly patients triggers cascading complications — drug interactions, fall risks, invasive follow-ups — that can strip away the very quality of life medicine aims to protect.
- The financial and psychological toll of unnecessary testing adds invisible weight: anxiety over ambiguous results, procedures that lead nowhere, and diagnoses that may never have caused harm.
- Medical experts are pushing for individualized care conversations that replace automatic protocol with honest dialogue about a patient's actual health, values, and remaining life goals.
- The path forward is not less medicine, but more intentional medicine — where doing less, when appropriate, becomes its own form of care.
There is a moment in the care of an aging patient when a routine screening arrives almost by habit — the same test ordered at fifty-five, repeated at sixty-eight because the protocol has not paused to ask whether it still makes sense. A growing body of evidence now suggests it should pause.
Many screenings and treatments were designed for younger populations, where early detection translates into meaningful years of extended life. Past sixty-five, that equation shifts. A test that once justified itself by preventing a heart attack or catching a cancer early may offer little life extension for someone whose remaining years are already shaped by other conditions. Yet the test still carries costs — financial, physical, and emotional. Abnormal results breed anxiety. Follow-up procedures carry risk. Treatments begun on findings that might never have caused harm can interact with other medications in unpredictable and damaging ways.
The cumulative burden of managing multiple diagnoses identified through aggressive screening can quietly diminish an older person's independence and comfort — a trade that grows harder to justify when the goal shifts from adding years to preserving the quality of the ones that remain.
The medical community is beginning to reckon with this honestly. Experts now call for individualized conversations between seniors and their doctors — not the abandonment of screening, but a more deliberate weighing of what each test or treatment is likely to accomplish against what it might cost a particular person. A healthy seventy-year-old with a strong cardiac history may benefit from preventive measures. A seventy-year-old managing several chronic conditions may not.
This recalibration asks something of both doctors and patients: a willingness to replace reflex with reflection, and to recognize that the most humane medicine sometimes means choosing, together, to do less.
At some point in the medical journey of an aging person, a doctor's recommendation for a routine screening or treatment arrives almost as reflex—the same test that made sense at fifty-five, ordered again at sixty-eight because that's what the protocol says to do. But a growing body of medical evidence suggests that after sixty-five, some of these standard interventions deserve a harder look. The calculus changes. Life expectancy shifts. The risk-benefit equation that justified a test decades earlier may no longer hold.
The core problem is straightforward: many screening tests and treatments were designed and validated for younger populations, where catching disease early typically means years of extended life ahead. For someone in their seventies or eighties, the math is different. A screening test that might prevent a heart attack or cancer diagnosis in a sixty-year-old may offer minimal life extension for someone whose remaining years are already limited by other conditions or simple biology. Yet the test itself carries real costs—not just financial, but physical and psychological. There is the anxiety of abnormal results. There are the follow-up procedures, some invasive. There are the side effects of treatments begun based on findings that might never have caused harm.
Overtreatment in older adults creates a cascade of complications that younger patients rarely face. When an elderly person takes multiple medications to manage conditions identified through screening, those drugs interact in ways that are difficult to predict. A medication that lowers blood pressure may cause dizziness, increasing fall risk. A treatment for one condition may worsen another. The cumulative burden of managing multiple diagnoses can actually diminish quality of life without extending it—a trade that makes little sense when the goal shifts from adding years to preserving the texture and independence of the years remaining.
The medical community is slowly acknowledging this reality. Experts now recommend that seniors over sixty-five have individualized conversations with their doctors about which screenings and treatments align with their actual health status and life goals, rather than following age-based protocols automatically. This is not an argument against all screening or treatment. It is an argument for intentionality. A seventy-year-old in excellent health with a strong family history of early heart disease may benefit from certain preventive measures. A seventy-year-old with multiple chronic conditions and limited mobility may not.
The shift requires a different kind of medical conversation—one where the doctor asks not just "What does the guideline say?" but "What does this person actually want?" Some seniors prioritize longevity above all else and welcome aggressive screening and treatment. Others value independence, comfort, and time with family more than an extra year or two gained through medical intervention. Neither choice is wrong. But the choice itself matters, and it cannot be made well without honest discussion about what the test or treatment is likely to accomplish and what it might cost.
For healthcare systems and individual patients alike, this recalibration offers a path toward more thoughtful, humane medicine in the later years—one that recognizes that not every test that can be done should be done, and that the best medical care sometimes means doing less.
Notable Quotes
Seniors should discuss individualized screening plans with doctors based on personal health status rather than following age-based protocols automatically— Medical experts and guidelines
The Hearth Conversation Another angle on the story
Why does a test that made sense at fifty suddenly become questionable at sixty-five?
Because the benefit shrinks. A screening test's value depends on how much extra life it buys you. At fifty, catching early cancer might mean decades ahead. At seventy-five, it might mean two years—if you're lucky. The test itself hasn't changed, but the math has.
But isn't catching disease early always good?
Not if the disease wouldn't have killed you anyway, or if treating it causes more harm than the disease itself. An older person might have a slow-growing cancer that would never cause symptoms. Finding it means years of treatment, worry, and side effects for a condition that would never have mattered.
What about the medications? Why do they become more dangerous?
An eighty-year-old's body processes drugs differently than a fifty-year-old's. Kidneys work slower. The liver is less efficient. Add five or six medications together and you get interactions nobody predicted. A blood pressure pill causes dizziness. The dizziness leads to a fall. The fall breaks a hip. Suddenly the treatment has created the real problem.
So doctors should just stop screening older patients?
No. They should ask first: What does this person want? What's their health like right now? What would this test actually change about their care? Some seventy-year-olds are vigorous and want every advantage. Others are frail and would rather spend their time with family than in doctors' offices. The answer isn't one-size-fits-all.
How do patients know which tests to question?
By having the conversation. Ask your doctor: If this test comes back abnormal, what would we do? Would that treatment extend my life or just extend my treatment? What are the side effects? Is there a reason to do this now, or are we just following routine? A good doctor will have answers.